Detalhe da pesquisa
1.
Determining minimal clinically important differences in the Hammersmith Functional Motor Scale Expanded for untreated spinal muscular atrophy patients: An international study.
Eur J Neurol
; : e16309, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38656662
2.
Different trajectories in upper limb and gross motor function in spinal muscular atrophy.
Muscle Nerve
; 64(5): 552-559, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34327716
3.
Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy.
Muscle Nerve
; 60(4): 409-414, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31298747
4.
Revised upper limb module for spinal muscular atrophy: 12 month changes.
Muscle Nerve
; 59(4): 426-430, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30677148
5.
Quantitative Evaluation of Lower Extremity Joint Contractures in Spinal Muscular Atrophy: Implications for Motor Function.
Pediatr Phys Ther
; 30(3): 209-215, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29924070
6.
Gait assessment with solesound instrumented footwear in spinal muscular atrophy.
Muscle Nerve
; 56(2): 230-236, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863443
7.
Advances in the Therapy of Spinal Muscular Atrophy.
J Pediatr
; 236: 13-20.e1, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34197889
8.
Six-minute walk test is reliable and valid in spinal muscular atrophy.
Muscle Nerve
; 54(5): 836-842, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27015431
9.
Beyond Contractures in Spinal Muscular Atrophy: Identifying Lower-Limb Joint Hypermobility.
J Clin Med
; 13(9)2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38731167
10.
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study.
Neurology
; 102(5): e209151, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38330285
11.
Disease Trajectories in the Revised Hammersmith Scale in a Cohort of Untreated Patients with Spinal Muscular Atrophy types 2 and 3.
J Neuromuscul Dis
; 11(3): 665-677, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38427497
12.
Assessing Bulbar Function in Spinal Muscular Atrophy Using Patient-Reported Outcomes.
J Neuromuscul Dis
; 10(2): 199-209, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36776075
13.
Nusinersen Treatment of Children with Later-Onset Spinal Muscular Atrophy and Scoliosis Is Associated with Improvements or Stabilization of Motor Function.
J Clin Med
; 12(15)2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568304
14.
Measuring Fatigue and Fatigability in Spinal Muscular Atrophy (SMA): Challenges and Opportunities.
J Clin Med
; 12(10)2023 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37240564
15.
Cerebrospinal Fluid Proteomic Changes after Nusinersen in Patients with Spinal Muscular Atrophy.
J Clin Med
; 12(20)2023 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37892834
16.
Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA).
J Clin Med
; 12(24)2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137651
17.
Development of an International SMA Bulbar Assessment for Inter-professional Administration.
J Neuromuscul Dis
; 10(4): 639-652, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212069
18.
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants.
J Clin Med
; 12(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36902710
19.
Clinical and Research Readiness for Spinal Muscular Atrophy: The Time Is Now for Knowledge Translation.
Phys Ther
; 102(10)2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35904447
20.
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes.
Neuromuscul Disord
; 32(1): 36-42, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34980538